First-Line Immuno-Oncology Therapies Up Survival in RCC With Brain Metastases
First-Line Immuno-Oncology Therapies Up Survival in RCC With Brain Met...
First-Line Immuno-Oncology Therapies Up Survival in RCC With Brain Met...
Fibrinolytic-deficiencies predispose hosts to septicemia from a cathet...
Erectile Dysfunction Drugs Plus Nitrates Tied to CV Morbidity and Mort...
Blocking lipid synthesis induces DNA damage in prostate cancer and inc...
Risk for Gout Flares With Initiation of Urate-Lowering Therapy Varies...
Cancer-associated fibroblasts promote enzalutamide resistance and PD-L...
Clinical validation of circulating GDF15/MIC‐1 as a marker of response...
Since research centers are considered as the most important pillar of science production throughout scientific centers and should have the art of converting experience into science, they should move in this direction with a plan and purpose to achieve this goal. In this regard, the center’s goal is to enter the base. The main principles of science and entry into technology are superior, so the laboratory of this center should be developed and also technology and invention should be the headline of the movement, which is being done and developed in several executive formats.
We hope to succeed in this great goal
Journal Club 2024.04.08 (1402.01.20) Dr. Beiranvand: Melatonin Attenuates Mitochondrial Damage in Aristolochic Acid-Induced Acute Kidney Injury doi: 10.4062/biomolther.2022.054 Aristolochic acid (AA), extracted from Aristolochiaceae plants, plays an essential role in traditional herbal medicines and is used for different diseases. However, AA has been found to be nephrotoxic and is known to cause aristolochic acid nephropathy (AAN). […]
read moreJournal Club 2024.03.04 (1402.12.14) 1- Dr. Beiranvand: Influence of unsaturated fatty acids on the antitumor activity of polymeric conjugates grafted with cabazitaxel against prostate cancer https://doi.org/10.1016/j.biopha.2023.115902 Cabazitaxel (CTX) is a medication used for treating metastatic prostate cancer. However, its effectiveness is majorly limited by its poor water solubility and lack of tumor targeting. In this study, three unsaturated […]
read moreJournal Club 2024.02.26 (1402.12.07) 1- Dr. Mohamadi: Pyuria as an independent predictor of intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial carcinoma https://doi.org/10.4111/icu.20230066 About one-third of patients who undergo radical nephroureterectomy (RNUx) for upper tract urothelial carcinoma (UTUC) experience intravesical recurrence (IVR). This study investigated whether pyuria is a feasible predictor of […]
read moreJournal Club 2024.02.19 (1402.11.30) 1-Dr. Mohamadi: Predictors of acute kidney injury after percutaneous nephrolithotomy in adult patients: prospective observational study https://link.springer.com/article/10.1007/s11255-024-03960-7 To assess the frequency and the predictive factors of Acute Kidney injury (AKI) in patients undergoing percutaneous nephrolithotomy (PNL). A prospective observational work. Demographic, preoperative laboratory data, stone characteristics, and intraoperative and postoperative data […]
read moreJournal Club 2024.02.12 (1402.11.23) 1- Dr. Mohamadi: Predictive value of prostate calcification for future cancer occurrence: a retrospective long-term follow-up cohort study https://doi.org/10.1259/bjr.20221110 Although prostate calcification is often identified on pelvic CT images, calcification itself is usually not considered clinically significant. A recent histological study proposed an association between prostate calcification and prostate cancer occurrence. […]
read moreJournal Club 2024.02.05 (1402.11.16) 1- Dr. Mohamadi: MRI-measured periprostatic adipose tissue volume as a prognostic predictor in prostate cancer patients undergoing laparoscopic radical prostatectomy https://doi.org/10.1080/21623945.2023.2201964 In this study, we evaluated the association between the PPAT volume and the prognosis of PCa patients after LRP. We retrospectively analysed data of 189 PCa patients who underwent LRP […]
read moreJournal Club 2024.01.29 (1402.11.09) 1- Dr.Mohamadi: Dilute povidone-iodine irrigation during percutaneous nephrolithotomy to reduce postoperative infective complications – Is there any benefit? doi: 10.4103/ua.ua_111_21 Infectious complications following stone lithotripsy is a significant source of patient morbidity and mortality. Post percutaneous nephrolithotomy fever is reported in 37% of patients undergoing PCNL and sepsis is the most common […]
read moreJournal Club 2024.01.22 (1402.11.02) 1- Dr. Mohamadi: The effect of screen time on the presentation and treatment of primary monosymptomatic nocturnal enuresis https://bmcurol.biomedcentral.com/articles/10.1186/s12894-023-01184-y We aimed to investigate if there was any relationship between screen time (ST) and the severity of primary monosymptomatic nocturnal enuresis (PMNE) and treatment success. This study was conducted in urology and […]
read moreJournal Club 2024.01.15 (1402.10.25) 1- Dr.GolMohamadi: Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274752/ Prostate cancer is usually considered as immune “cold” tumor with poor immunogenic response and low density of tumor-infiltrating immune cells, highlighting the need to explore clinically actionable strategies to sensitize prostate cancer to immunotherapy. In this study, […]
read moreJournal Club 2024.01.08 (1402.10.18) 1- Dr.GolMohamadi: Application of antibody-conjugated small intestine submucosa to capture urine-derived stem cells for bladder repair in a rabbit model. https://doi.org/10.1016/j.bioactmat.2021.11.017 The need for bladder reconstruction and side effects of cystoplasty have spawned the demand for the development of alternative material substitutes. Biomaterials such as submucosa of small intestine (SIS) have […]
read moreDetecting creditable urology research centers of the world to increase scientific communications and exchange ideas and bringing modern technology and urology for further scientific activities of Iranian researchers,
Training urology researchers,
Finding new methods of diagnosing and treating urologic diseases, esp. urogenital cancers using Nano medicine technology,
Applying stem-cell in treating urologic diseases,
Cooperate with relevant national research, executive centers for conducting research in the field of urology,
Promoting the awareness level of the public on urologic diseases for prevention, early diagnosis, timely treatment and decreasing complications, morbidity and mortality.
Urology Research Center, Sina Hospital, Hassan Abad Sq., Imam Khomeini Ave., Tehran, Iran
(+98) 6634 8560
urc@tums.ac.ir